OPTINOSE, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2017-11-27: Form 8-K; Period of report 2017-11-27; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2017-11-15: Form 8-K; Period of report 2017-11-15; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2017-10-18: Form 8-K; Period of report 2017-10-12; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2017-11-27 | 8-K | 2017-11-27 | 2.02 Results of Operations and Financial Condition | 2.02 On November 27, 2017, OptiNose, Inc. (the “Company”) issued a press release announcing its financial results for its third quarter ended September 30, 2017. | a8-kq317earningsrelease.htm |
| 2017-11-15 | 8-K | 2017-11-15 | 7.01 Regulation FD Disclosure | 7.01 On November 15, 2017, OptiNose, Inc. posted an updated Corporate Presentation on its website www.optinose.com. | a8-kjeffries_111517.htm |
| 2017-10-18 | 8-K | 2017-10-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 5.02 OptiNose, Inc. (the “Company”), through its wholly-owned subsidiary, has entered into employment agreements with each of Peter K. Miller, Dr. Ramy A. Mahmoud, Thomas E. Gibbs, Keith A. Goldan and Michael F. Marino (each, an “Executive Employment Agreement” and, collectively, the “Executive Employment Agreements”), effective as of the closing of the Company’s initial public offering of shares of its common stock (the “IPO”) on October 17, 2017. 5.03 On October 17, 2017, the Company filed its Fourth Amended and Restated Certificate of Incorporation (the “Amended Certificate”) with the Secretary of State of the State of Delaware in connection with the closing of the IPO. 8.01 On October 17, 2017, the Company completed its IPO of 8,625,000 shares of its common stock at a price to the public of $16.00 per share, which includes the exercise in full by the underwriters of their option to purchase 1,125,000 shares of the Company’s common stock. | a17-15165_178k.htm |